Melatonin in Youth: N-of-1 trials in a stimulant-treated ADHD Population (MYNAP): study protocol for a randomized controlled trial.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27473269)

Published in Trials on July 29, 2016

Authors

Salima Punja1, Catherine J Nikles2, Hugh Senior3,4, Geoffrey Mitchell4, Christopher H Schmid5, Helen Heussler6, Manisha Witmans7, Sunita Vohra8

Author Affiliations

1: Complementary and Alternative Research Education (CARE) Program, Department of Pediatrics, University of Alberta, #1702 College Plaza, 8512-112 Street NW, Edmonton, Alberta, T6G 2C8, Canada.
2: Center for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.
3: College of Health, Massey University, Auckland, New Zealand.
4: Discipline of General Practice, The University of Queensland, Brisbane, Queensland, Australia.
5: Department of Biostatistics and Center for Evidence Based Medicine, School of Public Health, Brown University, Providence, Rhode Island, USA.
6: Lady Cilento Children's Hospital, Brisbane, Australia.
7: Alberta Health Services, Edmonton, Alberta, Canada.
8: Complementary and Alternative Research Education (CARE) Program, Department of Pediatrics, University of Alberta, #1702 College Plaza, 8512-112 Street NW, Edmonton, Alberta, T6G 2C8, Canada. svohra@ualberta.ca.

Associated clinical trials:

Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population (MYNAP) | NCT02333149

Articles cited by this

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care (1996) 70.87

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA (1998) 5.96

Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry (1993) 4.71

Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep (2010) 3.54

Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am (2000) 3.25

Actigraphy validation with insomnia. Sleep (2006) 3.14

Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry (1998) 2.90

Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry (2000) 2.80

The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view. Ment Retard Dev Disabil Res Rev (2002) 2.76

Recent trends in stimulant medication use among U.S. children. Am J Psychiatry (2006) 2.52

Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2002) 2.32

Evaluation of chronic insomnia. An American Academy of Sleep Medicine review. Sleep (2000) 2.20

Long-term prognosis in attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am (2000) 2.18

Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ (2006) 2.09

Unravelling sleep problems in treated and untreated children with ADHD. J Child Adolesc Psychopharmacol (1999) 1.76

Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics (2001) 1.72

Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry (1997) 1.62

Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics (1997) 1.55

DSM-IV AD/HD: confirmatory factor models, prevalence, and gender and age differences based on parent and teacher ratings of Australian primary school children. J Child Psychol Psychiatry (1999) 1.39

Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry (2007) 1.29

The pediatric cancer quality of life inventory-32 (PCQL-32): I. Reliability and validity. Cancer (1998) 1.28

Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry (2006) 1.15

Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis. Dev Med Child Neurol (2009) 1.12

Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol (2001) 1.08

Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics (2003) 1.05

Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. J Am Acad Child Adolesc Psychiatry (2003) 1.04

Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res (1996) 1.03

Economic implications of attention-deficit hyperactivity disorder for healthcare systems. Pharmacoeconomics (2003) 1.01

Sleep hygiene and actigraphically evaluated sleep characteristics in children with ADHD and chronic sleep onset insomnia. J Sleep Res (2006) 0.94

Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder. Ann Pharmacother (2009) 0.91

Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder. Chronobiol Int (2005) 0.90

Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales. N S W Public Health Bull (2002) 0.88

Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus. FASEB J (1999) 0.85

Pharmacological and non-pharmacological management of sleep disturbance in children: an Australian Paediatric Research Network survey. Sleep Med (2012) 0.84

Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study. Eur J Pediatr (2003) 0.83

Melatonin and 6-hydroxymelatonin sulfate excretion is inversely correlated with gonadal development in children. Horm Res (1997) 0.81

Physiological effects of light on the human circadian pacemaker. Semin Perinatol (2000) 0.80

More on melatonin. J Am Acad Child Adolesc Psychiatry (1997) 0.76